Helicos BioSciences (HLCS) Names Lowy as CEO
More News related to HLCS
- Helicos BioSciences (HLCS) Comments on Q3 Operations
- Helicos BioSciences Q3 2009 Operating Highlights and Strategic Update
- Helicos (HLCS) Receives $1000 Award From the National Human Genome Research Institute
- Helicos BioSciences Receives $1000 Genome Award
- After-Hours Movers 9/30: CPRX, XRTX, BCRX, BAC Higher; PAG, AST, UAUA, HLCS, DMND Lower
Helicos BioSciences (NASDAQ: HLCS) announced today that its Board of Directors has appointed Ronald Lowy as the company's CEO, effective immediately.
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.
Related Categories
Management ChangesStocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
